1. Home
  2. PHR vs SPRY Comparison

PHR vs SPRY Comparison

Compare PHR & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHR
  • SPRY
  • Stock Information
  • Founded
  • PHR 2005
  • SPRY 2015
  • Country
  • PHR United States
  • SPRY United States
  • Employees
  • PHR N/A
  • SPRY N/A
  • Industry
  • PHR Business Services
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • PHR Consumer Discretionary
  • SPRY Health Care
  • Exchange
  • PHR Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • PHR 1.5B
  • SPRY 1.8B
  • IPO Year
  • PHR 2019
  • SPRY N/A
  • Fundamental
  • Price
  • PHR $31.99
  • SPRY $13.44
  • Analyst Decision
  • PHR Strong Buy
  • SPRY Strong Buy
  • Analyst Count
  • PHR 14
  • SPRY 4
  • Target Price
  • PHR $32.07
  • SPRY $28.75
  • AVG Volume (30 Days)
  • PHR 686.3K
  • SPRY 1.9M
  • Earning Date
  • PHR 09-04-2025
  • SPRY 08-13-2025
  • Dividend Yield
  • PHR N/A
  • SPRY N/A
  • EPS Growth
  • PHR N/A
  • SPRY N/A
  • EPS
  • PHR N/A
  • SPRY N/A
  • Revenue
  • PHR $434,532,000.00
  • SPRY $112,339,000.00
  • Revenue This Year
  • PHR $14.74
  • SPRY N/A
  • Revenue Next Year
  • PHR $11.57
  • SPRY $182.40
  • P/E Ratio
  • PHR N/A
  • SPRY N/A
  • Revenue Growth
  • PHR 16.29
  • SPRY 22367.80
  • 52 Week Low
  • PHR $17.07
  • SPRY $10.00
  • 52 Week High
  • PHR $32.11
  • SPRY $18.90
  • Technical
  • Relative Strength Index (RSI)
  • PHR 72.03
  • SPRY 32.98
  • Support Level
  • PHR $27.00
  • SPRY $13.32
  • Resistance Level
  • PHR $29.45
  • SPRY $15.09
  • Average True Range (ATR)
  • PHR 1.17
  • SPRY 0.99
  • MACD
  • PHR 0.39
  • SPRY -0.24
  • Stochastic Oscillator
  • PHR 97.50
  • SPRY 2.62

About PHR Phreesia Inc.

Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: